Follow this preprint
Vaccine effectiveness when combining the ChAdOx1 vaccine as the first dose with an mRNA COVID-19 vaccine as the second dose
View ORCID ProfileMie Agermose Gram, View ORCID ProfileJens Nielsen, View ORCID ProfileAstrid Blicher Schelde, Katrine Finderup Nielsen, View ORCID ProfileIda Rask Moustsen-Helms, Anne Katrine Bjørkholt Sørensen, View ORCID ProfilePalle Valentiner-Branth, View ORCID ProfileHanne-Dorthe Emborg
doi: https://doi.org/10.1101/2021.07.26.21261130
Now published in PLOS Medicine doi: 10.1371/journal.pmed.1003874
Mie Agermose Gram
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark
Jens Nielsen
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark
Astrid Blicher Schelde
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark
Katrine Finderup Nielsen
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark
Ida Rask Moustsen-Helms
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark
Anne Katrine Bjørkholt Sørensen
2Department of Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark
Palle Valentiner-Branth
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark
Hanne-Dorthe Emborg
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark

Data Availability
Because of data protection regulation, data cannot be shared directly by the authors. Data is accessible to researchers from an authorised institution after permission from the Danish Data Protection Agency and Danish Health and Medicines Authority
Posted July 28, 2021.
Vaccine effectiveness when combining the ChAdOx1 vaccine as the first dose with an mRNA COVID-19 vaccine as the second dose
Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Anne Katrine Bjørkholt Sørensen, Palle Valentiner-Branth, Hanne-Dorthe Emborg
medRxiv 2021.07.26.21261130; doi: https://doi.org/10.1101/2021.07.26.21261130
Now published in PLOS Medicine doi: 10.1371/journal.pmed.1003874
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
3
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (418)
- Allergy and Immunology (740)
- Anesthesia (217)
- Cardiovascular Medicine (3179)
- Dermatology (268)
- Emergency Medicine (469)
- Epidemiology (13154)
- Forensic Medicine (18)
- Gastroenterology (879)
- Genetic and Genomic Medicine (4987)
- Geriatric Medicine (458)
- Health Economics (764)
- Health Informatics (3142)
- Health Policy (1115)
- Hematology (418)
- HIV/AIDS (988)
- Medical Education (462)
- Medical Ethics (122)
- Nephrology (511)
- Neurology (4736)
- Nursing (252)
- Nutrition (700)
- Oncology (2437)
- Ophthalmology (692)
- Orthopedics (272)
- Otolaryngology (335)
- Pain Medicine (315)
- Palliative Medicine (88)
- Pathology (524)
- Pediatrics (1265)
- Primary Care Research (539)
- Public and Global Health (7301)
- Radiology and Imaging (1641)
- Respiratory Medicine (954)
- Rheumatology (468)
- Sports Medicine (411)
- Surgery (528)
- Toxicology (66)
- Transplantation (226)
- Urology (196)